These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 2312443)
1. Pharmacokinetics of sodium fusidate after single and repeated infusions and oral administration of a new formulation. Taburet AM; Guibert J; Kitzis MD; Sorensen H; Acar JF; Singlas E J Antimicrob Chemother; 1990 Feb; 25 Suppl B():23-31. PubMed ID: 2312443 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of fusidic acid after a single dose of a new paediatric suspension. Bourget P; Duhamel JF; Sørensen H; Roiron R J Clin Pharm Ther; 1993 Jun; 18(3):171-7. PubMed ID: 8345001 [TBL] [Abstract][Full Text] [Related]
3. Antibiotic activity in serum following single and repeated oral administration of sodium fusidate in volunteers. Munkholm P; Hey H; Rasmussen SN; Johansen PB Eur J Drug Metab Pharmacokinet; 1994; 19(4):337-41. PubMed ID: 7737235 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and tolerance of a new film-coated tablet of sodium fusidate administered as a single oral dose to healthy volunteers. MacGowan AP; Greig MA; Andrews JM; Reeves DS; Wise R J Antimicrob Chemother; 1989 Mar; 23(3):409-15. PubMed ID: 2732122 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and tolerance of a new film-coated tablet of sodium fusidate administered as a single oral dose to healthy volunteers. Macgowan AP; Greig MA; Andrews JM; Reeves DS; Wise R J Chemother; 1989 Jul; 1(4 Suppl):593-6. PubMed ID: 16312548 [No Abstract] [Full Text] [Related]
6. Population pharmacokinetics of fusidic acid: rationale for front-loaded dosing regimens due to autoinhibition of clearance. Bulitta JB; Okusanya OO; Forrest A; Bhavnani SM; Clark K; Still JG; Fernandes P; Ambrose PG Antimicrob Agents Chemother; 2013 Jan; 57(1):498-507. PubMed ID: 23147726 [TBL] [Abstract][Full Text] [Related]
7. The disposition of sodium fusidate in man. Wise R; Pippard M; Mitchard M Br J Clin Pharmacol; 1977 Oct; 4(5):615-9. PubMed ID: 911608 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and bioavailability of dilevalol in normotensive volunteers. Kramer WG; Nagabhushan N; Affrime MB; Perentesis GP; Symchowicz S; Patrick JE J Clin Pharmacol; 1988 Jul; 28(7):644-8. PubMed ID: 3216030 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of hydroxy-3(S)-dihydroquinidine in healthy volunteers after intravenous and oral administration. Jaillon P; Poirier JM; Lecocq B; Jarreau C; Pays M; Richard MO; Cheymol G Eur J Drug Metab Pharmacokinet; 1986; 11(3):233-8. PubMed ID: 3816879 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of intravenous fusidic acid in patients with cholestasis. Peter JD; Jehl F; Pottecher T; Dupeyron JP; Monteil H Antimicrob Agents Chemother; 1993 Mar; 37(3):501-6. PubMed ID: 8460918 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of intravenous and oral enoxacin in healthy volunteers. Chang T; Black A; Dunky A; Wolf R; Sedman A; Latts J; Welling PG J Antimicrob Chemother; 1988 Feb; 21 Suppl B():49-56. PubMed ID: 3162901 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of pefloxacin after repeated intravenous and oral administration (400 mg bid) in young healthy volunteers. Frydman AM; Le Roux Y; Lefebvre MA; Djebbar F; Fourtillan JB; Gaillot J J Antimicrob Chemother; 1986 Apr; 17 Suppl B():65-79. PubMed ID: 3458699 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of chlorprothixene after single intravenous and oral administration of three galenic preparations. Bagli M; Rao ML; Höflich G; Kasper S; Langer M; Barlage U; Beneke M; Süverkrüp R; Möller HJ Arzneimittelforschung; 1996 Mar; 46(3):247-50. PubMed ID: 8901143 [TBL] [Abstract][Full Text] [Related]
14. Cilostazol pharmacokinetics after single and multiple oral doses in healthy males and patients with intermittent claudication resulting from peripheral arterial disease. Bramer SL; Forbes WP; Mallikaarjun S Clin Pharmacokinet; 1999; 37 Suppl 2():1-11. PubMed ID: 10702882 [TBL] [Abstract][Full Text] [Related]
15. Zatebradine: pharmacokinetics of a novel heart-rate-lowering agent after intravenous infusion and oral administration to healthy subjects. Roth W; Bauer E; Heinzel G; Cornelissen PJ; van Tol RG; Jonkman JH; Zuiderwijk PB J Pharm Sci; 1993 Jan; 82(1):99-106. PubMed ID: 8429501 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults. Markowitz JS; Straughn AB; Patrick KS; DeVane CL; Pestreich L; Lee J; Wang Y; Muniz R Clin Pharmacokinet; 2003; 42(4):393-401. PubMed ID: 12648029 [TBL] [Abstract][Full Text] [Related]
18. Study on the absolute bioavailability of quinine and theophylline from tablets after single dose oral administration as compared to intravenous infusion in healthy male non-smoking volunteers. Fuder H; Herzog R; Vaupel W; Wetzelsberger N; Lücker PW Methods Find Exp Clin Pharmacol; 1994 Nov; 16(9):651-60. PubMed ID: 7746027 [TBL] [Abstract][Full Text] [Related]
19. Safety, Tolerability, and Pharmacokinetic Properties of Intravenous Delafloxacin After Single and Multiple Doses in Healthy Volunteers. Hoover R; Hunt T; Benedict M; Paulson SK; Lawrence L; Cammarata S; Sun E Clin Ther; 2016 Jan; 38(1):53-65. PubMed ID: 26718605 [TBL] [Abstract][Full Text] [Related]